Companies Cryptocurrencies
Milestone Pharmaceuticals Inc
Milestone Pharmaceuticals Inc
Exchange: NasdaqGS
IPO Date: 09/05/2019
CEO: Mr. Joseph G. Oliveto
Biotechnology Healthcare 🔗
  • MIST
  • 5.6
  • 167137600
    market cap
  • 0.11000013
If you bought

shares of Milestone Pharmaceuticals Inc (MIST) on
You would have made
Old Price $12 Current Price $12

Milestone Pharmaceuticals, Inc. is a biopharmaceutical company. The company is headquartered in Saint-Laurent, Quebec and currently employs 23 full-time employees. The firm is focused on developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is its short-acting calcium channel blocker. The company is developing Etripamil as a nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia (PSVT), as they occur. The company is also focused on developing treatments for other indications, such as Atrial Fibrillation and Angina. Etripamil is in Phase-III development for PSVT.

Address: 1111 Dr.-Frederik-Philips Blvd Suite 420 Saint-Laurent QUEBEC H4M 2X6

Stay updated.